Amphastar Pharmaceuticals (AMPH) Total Debt Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) Total Debt Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 41.53% |
| 10 | Amphastar Pharmaceuticals | 945.98 Mn | 655.86 Mn | 93.47 Mn | 0.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.56% |
| Mar 31, 2026 | 1.22% |
| Dec 31, 2025 | 1.42% |
| Sep 30, 2025 | 2.15% |
| Jun 30, 2025 | 3.67% |
| Mar 31, 2025 | 1.62% |
| Dec 31, 2024 | 2.01% |
| Sep 30, 2024 | -6.57% |
| Jun 30, 2024 | 17.14% |
| Mar 31, 2024 | 692.16% |
| Dec 31, 2023 | 677.51% |
| Sep 30, 2023 | 743.74% |
| Jun 30, 2023 | 560.10% |
| Mar 31, 2023 | -1.92% |
| Dec 31, 2022 | -1.42% |
| Sep 30, 2022 | -2.72% |
| Jun 30, 2022 | 97.03% |
| Mar 31, 2022 | 71.90% |
| Dec 31, 2021 | 65.73% |
| Sep 30, 2021 | 72.64% |